PTAB Backs 3 Oracea Patents In 1st-Ever Pharma AIA Ruling
The Patent Trial and Appeal Board on Tuesday blocked a bid to invalidate Supernus Pharmaceuticals Inc.'s three patents for rosacea treatment Oracea, marking the first-ever successful defense of a pharmaceutical patent...To view the full article, register now.
Already a subscriber? Click here to view full article